Aptose Presents Early Phase 1a/b CG-806 Clinical Findings at the 25th Congress of the European Hematology AssociationGlobeNewsWire • 06/12/20
Aptose Biosciences' (APTO) CEO William Rice on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/06/20
Aptose Presents Preliminary Clinical Data on CG-806 at AACR Virtual Annual Meeting 2020GlobeNewsWire • 04/27/20
Aptose Biosciences Inc. (APTO) CEO William Rice on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/11/20
Are Options Traders Betting on a Big Move in Aptose (APTO) Stock?Zacks Investment Research • 02/21/20
Aptose Biosciences, Inc. (APTO) CEO William Rice on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/06/19
Aptose to Participate at 5th International Conference on Acute Myeloid Leukemia of the European School of Haematology (ESH)GlobeNewsWire • 10/10/19
Aptose to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease CompaniesGlobeNewsWire • 09/16/19
Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19
Aptose Biosciences Inc. (APTO) CEO William Rice on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/08/19
Aptose Biosciences Inc. (APTO) CEO William Rice on Q4 2018 Results - Earnings Call TranscriptSeeking Alpha • 03/13/19